Cookies?
Library Header Image
LSE Research Online LSE Library Services

Cost-effectiveness of pertussis booster vaccination in the Netherlands

Rozenbaum, Mark H., De Cao, Elisabetta ORCID: 0000-0002-7769-486X and Postma, Maarten (2012) Cost-effectiveness of pertussis booster vaccination in the Netherlands. Vaccine, 30 (50). 7327 - 7331. ISSN 0264-410X

Full text not available from this repository.

Identification Number: 10.1016/j.vaccine.2012.06.026

Abstract

The aim of the current study is to estimate the epidemiological and economical consequences of several extended pertussis booster vaccination strategies and to explore the impact of parameters surrounded by large uncertainty on the cost-effectiveness. We developed an age structured transmission dynamic model to evaluate the impact of programs targeting (i) adolescents or adults using a single booster dose, (ii) a combination of adolescent and adult vaccination, and (iii) an every 10 years booster dose. The base case analysis, that is a single adolescent booster administered at the age of 12 years, resulted in a reduction of pertussis infections. However, due to an increase in the number of symptomatic infections in adults, the benefits in terms of QALYs gained and costs saved in children were partly offset. Despite these negative indirect effects in the adult population, administering an additional booster dose could still be considered cost effective with an ICER of €4200 per QALY gained. Combining an adolescent booster dose at the age of 10 (most cost-effective age for a single adolescent booster dose) with an adult (18–30 years) booster dose always resulted in favorable ICERs (<€10,000/QALY). Finally the every 10 year booster dose resulted in an ICER of €16,900 per QALY. The impact of different assumptions regarding the disease epidemiology, disease-related parameters, and vaccination program-related issues was limited. To conclude, we show that extended pertussis booster vaccination strategies are likely to be considered as cost-effective.

Item Type: Article
Official URL: https://www.sciencedirect.com/journal/vaccine
Additional Information: © 2012 Crown Copyright
Divisions: Health Policy
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Date Deposited: 30 Sep 2019 10:33
Last Modified: 15 Nov 2024 17:24
URI: http://eprints.lse.ac.uk/id/eprint/101595

Actions (login required)

View Item View Item